Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oliva Therapeutics is a privately held healthcare company focused on the commercialization, sales, marketing, distribution, and promotion of high-quality pharmaceutical products. The company has launched generic medications such as Digoxin Tablets and distributes branded products like Thyquidity® in partnership with Jerome Stevens Pharmaceuticals. It recently entered into an exclusive North American supply/distribution agreement with Rio Biopharmaceuticals to expand its portfolio further. Initial product launches from this partnership are expected in 2024 with additional launches over the following two years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oliva Therapeutics.